First Trust Advisors LP Acquires 10,987 Shares of Exponent, Inc. (NASDAQ:EXPO)

First Trust Advisors LP boosted its holdings in Exponent, Inc. (NASDAQ:EXPO) by 14.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 89,464 shares of the business services provider’s stock after buying an additional 10,987 shares during the quarter. First Trust Advisors LP owned approximately 0.17% of Exponent worth $7,240,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. raised its holdings in Exponent by 46.1% in the 1st quarter. JPMorgan Chase & Co. now owns 46,529 shares of the business services provider’s stock valued at $3,345,000 after buying an additional 14,674 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in Exponent by 6.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 148,449 shares of the business services provider’s stock worth $10,244,000 after purchasing an additional 8,426 shares during the last quarter. BNP Paribas Arbitrage SA raised its holdings in Exponent by 132.7% during the 1st quarter. BNP Paribas Arbitrage SA now owns 34,111 shares of the business services provider’s stock worth $2,453,000 after purchasing an additional 19,454 shares during the last quarter. Parametric Portfolio Associates LLC raised its holdings in Exponent by 3.0% during the 1st quarter. Parametric Portfolio Associates LLC now owns 205,925 shares of the business services provider’s stock worth $14,808,000 after purchasing an additional 5,965 shares during the last quarter. Finally, Swiss National Bank raised its holdings in Exponent by 1.2% during the 1st quarter. Swiss National Bank now owns 100,500 shares of the business services provider’s stock worth $7,227,000 after purchasing an additional 1,200 shares during the last quarter. Institutional investors and hedge funds own 88.81% of the company’s stock.

In related news, VP Bradley A. James sold 4,370 shares of Exponent stock in a transaction on Monday, May 18th. The shares were sold at an average price of $67.56, for a total value of $295,237.20. Following the completion of the sale, the vice president now owns 3,120 shares of the company’s stock, valued at approximately $210,787.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Harri Kytomaa sold 1,700 shares of Exponent stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $75.07, for a total transaction of $127,619.00. Following the completion of the sale, the vice president now directly owns 10,661 shares of the company’s stock, valued at approximately $800,321.27. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 60,070 shares of company stock valued at $4,545,523. Insiders own 2.20% of the company’s stock.

Shares of EXPO stock opened at $84.06 on Friday. The company has a market cap of $4.33 billion, a price-to-earnings ratio of 55.30 and a beta of 0.26. Exponent, Inc. has a 52 week low of $58.03 and a 52 week high of $84.34. The company has a quick ratio of 3.81, a current ratio of 3.81 and a debt-to-equity ratio of 0.05. The firm has a 50 day moving average of $78.81 and a 200-day moving average of $73.63.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Thursday, July 30th. The business services provider reported $0.31 EPS for the quarter, topping the consensus estimate of $0.22 by $0.09. The company had revenue of $87.86 million during the quarter, compared to the consensus estimate of $85.11 million. Exponent had a net margin of 19.87% and a return on equity of 23.68%. Analysts anticipate that Exponent, Inc. will post 1.33 earnings per share for the current year.

Several research analysts have issued reports on EXPO shares. Sidoti raised their price target on shares of Exponent from $80.00 to $94.00 and gave the stock a “buy” rating in a report on Tuesday, June 2nd. BidaskClub upgraded shares of Exponent from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Zacks Investment Research lowered shares of Exponent from a “hold” rating to a “sell” rating in a report on Friday, July 3rd. One analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $86.75.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Read More: Price Target

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply